News
-
A lab professional’s dedication to urgent, accurate COVID-19 testing
Suzanne Dale, who serves as the technical director of molecular biology at LabCorp, has been on the frontlines of the COVID-19 pandemic since the very start. In her role at LabCorp’s Center for Esoteric Testing in North Carolina, Suzanne has been an essential member of the COVID-19 response team – working to make sure that all COVID-19 diagnostic tests that run through her labContinue Reading »... -
Access To COVID-19 Testing Fact Sheet
... -
With the help of clinical labs, “The Fight Is In Us” aims to boost convalescent plasma donations nationwide
ACLA member laboratories have been committed from the earliest stages of this pandemic to do everything possible to support the fight against COVID-19, performing nearly 27 million molecular tests for the virus while pioneering a wide range of innovative approaches to meet testing demand. As part of our ongoing work to support public health partners, ACLA is proud to support efforts to significantly increase donations ofContinue Reading »... -
ACLA Statement on Senate Republicans’ Coronavirus Relief Package
WASHINGTON, D.C. — Following the release of Senate Republicans’ coronavirus relief package, ACLA President Julie Khani issued the following statement: “ACLA is currently reviewing the Senate Republicans’ coronavirus relief package. At a time when the country is focused on protecting millions of people who are returning to work and school, Americans need a clear federal standard on coverage for testing performed for return-to-work, return-to-school,Continue Reading »... -
Data Reporting for COVID-19 Testing
Information and Resources for Providers Overview Since the start of the COVID-19 public health emergency, clinical laboratories have worked closely with the provider community and public health officials to ensure relevant patient information is included in COVID-19 test orders. This critical data helps inform prevention, surveillance and mitigation efforts across the country, including identifying patients at higher risk for infection, hospitalization and death fromContinue Reading »... -
Patients, Employers, Labs and Health Insurance Providers Call on Congress to Dedicate Funding for COVID-19 Testing to Get America Back to Work and School
WASHINGTON, D.C. – The National Consumers League, the American Clinical Laboratory Association (ACLA) and America’s Health Insurance Plans (AHIP) joined nearly 50 leading stakeholders representing patients, employers, clinical laboratories, health insurance providers and other leaders from across health care community yesterday in sending a letter to congressional leadership requesting dedicated federal funding for the critical testing needed to reopen the country. “Every American, especiallyContinue Reading »... -
Testing Fund Stakeholder Letter
... -
Behind the Scenes Responding to COVID-19
Across the country, clinical laboratory professionals are hard at work developing innovative testing methods and performing complex diagnostic tests for COVID-19. Chris Burns, an instrument specialist at ARUP, is one of the many lab professionals helping to process ARUP’s COVID-19 molecular diagnostic test for patients each day. In his role at ARUP’s lab in Utah, Chris has been a vital member of the team,Continue Reading »... -
ACLA Update on PCR Testing Capacity for COVID-19
WASHINGTON, D.C. – As ACLA member laboratories continue to navigate unprecedented demand and significant supply challenges, ACLA President Julie Khani issued the following statement: “In light of the ongoing spread of COVID-19 in states across the country, many labs are now receiving more test orders than they are able to process in a single day. We have urged ordering providers to prioritize testing forContinue Reading »... -
ACLA Letter to Chairman Lamar Alexander on Pandemic Response White Paper
...
